Cyclerion Therapeutics, Inc.·4

Aug 7, 4:05 PM ET

Graul Regina Margaret 4

4 · Cyclerion Therapeutics, Inc. · Filed Aug 7, 2024

Insider Transaction Report

Form 4
Period: 2024-08-05
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-05+55,84955,849 total
    Exercise: $3.30Exp: 2034-08-05Common Stock (55,849 underlying)
Footnotes (1)
  • [F1]The Reporting Person was granted an option to purchase up to 55,849 shares of the Corporation's common stock pursuant to the 2019 Equity Incentive Plan. These 55,849 shares vest ratably in monthly installments over a 48-month period commencing August 31, 2024 and ending July 31, 2028, provided that the Reporting Person remains employed by Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4